RAD51-IN-1
RAD51-IN-1, a derivative of B02, is a potent inhibitor of RAD51. RAD51-IN-1 can be used for cancer research[1].
Product Specifications
CAS Number
[2101739-18-6]
UNSPSC
12352005
Hazard Statement
H315, H319
Target
RAD51
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/rad51-in-1.html
Purity
99.89
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
O=C1N(CC2=CC=C(Cl)C=C2)C(/C=C/C3=CC=CN=C3)=NC4=C1C=CC=C4
Molecular Formula
C22H16ClN3O
Molecular Weight
373.83
Precautions
H315, H319
References & Citations
[1]Ambber Ward, et al. Quinazolinone derivatives as inhibitors of homologous recombinase RAD51. Bioorg Med Chem Lett. 2017 Jul 15;27 (14) :3096-3100.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
122942-ML550 100 µL
ACTRT2 (Actin-related Protein T2, Actin-related Protein M2, ARPM2, ARPT2, ARP-T2, FLJ25424, HARPM2) (MaxLight 550)
Ask
View Details 
